166 related articles for article (PubMed ID: 1569702)
1. [Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. 1. Histological mapping specimen and morphological quantitative analysis].
Oikawa T
Nihon Shokakibyo Gakkai Zasshi; 1992 Feb; 89(2):477-85. PubMed ID: 1569702
[TBL] [Abstract][Full Text] [Related]
2. [Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. II. Immunohistochemical quantitative analysis].
Oikawa T
Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):601-9. PubMed ID: 1578804
[TBL] [Abstract][Full Text] [Related]
3. Mucin profiles in ulcerative colitis with dysplasia and carcinoma.
Allen DC; Connolly NS; Biggart JD
Histopathology; 1988 Oct; 13(4):413-24. PubMed ID: 3220466
[TBL] [Abstract][Full Text] [Related]
4. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Zhuang Z; Poremba C; Dockhorn-Dworniczak B; Vortmeyer A
Oncol Rep; 1998; 5(2):477-80. PubMed ID: 9468583
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
6. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
7. Malignant potential of chronic ulcerative colitis. Preliminary report.
Nugent FW; Haggit RC; Colcher H; Kutteruf GC
Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
[TBL] [Abstract][Full Text] [Related]
8. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study.
Befrits R; Hammarberg C; Rubio C; Jaramillo E; Tribukait B
Dis Colon Rectum; 1994 Apr; 37(4):313-9; discussion 319-20. PubMed ID: 8168409
[TBL] [Abstract][Full Text] [Related]
9. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
Gorfine SR; Bauer JJ; Harris MT; Kreel I
Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
[TBL] [Abstract][Full Text] [Related]
11. Distribution of dysplasia in ulcerative colitis.
Vatn MH; Elgjo K; Bergan A
Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
[TBL] [Abstract][Full Text] [Related]
13. How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?
Riddell RH
J Gastrointest Surg; 1998; 2(4):314-7. PubMed ID: 9917185
[No Abstract] [Full Text] [Related]
14. [The choice of tactics in the treatment of nonspecific ulcerative colitis].
Ioffe AIu
Klin Khir; 2005 Sep; (9):9-11. PubMed ID: 16445035
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?
Löfberg R; Tribukait B; Ost A; Broström O; Reichard H
Gut; 1987 Sep; 28(9):1100-6. PubMed ID: 3678969
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
Matsuda K; Watanabe H; Ajioka Y; Kobayashi M; Saito H; Sasaki M; Yasuda K; Kuwabara A; Nishikura K; Muto T
J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
[TBL] [Abstract][Full Text] [Related]
17. Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia.
Agawa S; Muto T; Morioka Y
Dis Colon Rectum; 1988 May; 31(5):387-9. PubMed ID: 2452723
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different techniques for detection of Gal-GalNAc, an early marker of colonic neoplasia.
Said IT; Shamsuddin AM; Sherief MA; Taleb SG; Aref WF; Kumar D
Histol Histopathol; 1999 Apr; 14(2):351-7. PubMed ID: 10212796
[TBL] [Abstract][Full Text] [Related]
19. Non-dysplastic villous changes in endoscopic biopsies in ulcerative colitis with carcinoma.
Rubio CA; Nylander G; Johansson C; Slezak P
Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):277-82. PubMed ID: 6289600
[TBL] [Abstract][Full Text] [Related]
20. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.
Andrews CW; Jessup JM; Goldman H; Hayes DF; Kufe DW; O'Hara CJ; Steele GD
Cancer; 1993 Dec; 72(11):3185-90. PubMed ID: 7694786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
